Peprazom/Peprazom IV Indications/Uses

Peprazom: Symptomatic treatment of gastroesophageal reflux disease (GERD) and erosive reflux esophagitis.
Long-term management of patients with healed esophagitis to prevent relapse. In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori and healing associated with duodenal ulcer; prevention of relapse of peptic ulcers in patients with Helicobacter pylori-associated ulcers.
Patients requiring continued NSAID therapy; healing of gastric ulcers associated with NSAID therapy; prevention of gastric and duodenal ulcers associated with NSAID therapy in patients at risk.
Prolonged treatment after IV-induced prevention of rebleeding of peptic ulcers.
Treatment of Zollinger-Ellison syndrome.
Peprazom IV: Esomeprazole (Peprazom IV) 40 mg Powder for Solution for Injection is indicated for: Adults: Gastric antisecretory treatment when the oral route is not possible, such as: Gastroesophageal reflux disease (GERD) in patients with esophagitis and/or severe symptoms of reflux.
Healing of gastric ulcers associated with NSAID therapy.
Prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk.
Prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.
Children and adolescents aged 1-18 years: Gastric antisecretory treatment when the oral route is not possible, such as: Gastroesophageal reflux disease in patients with erosive reflux esophagitis and/or severe symptoms of reflux.